UNSPSC 51262914: Propranolol hydrochloride

This classification denotes a beta-adrenergic blocking agent with the molecular formula C16H21NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F8A3652H1V, chemically known as 2-propanol, 1- (isopropylamino)-3-(1-naphthyloxy)-, hydrochloride but more generally known as propranolol hydrochloride, which bears US NIH Compound Identifier 4946. European Medicines Agency schedules Propranolol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04091MIG.

UNSPSC 51262914 Propranolol hydrochloride is a Commodity code that in recent state and local procurement activity encompasses not pharmaceutical products themselves but rather broader health and pharmacy benefit initiatives — specifically the acquisition of naloxone and drug deactivation systems, and the exploration of direct-to-manufacturer prescription fulfillment models. The mismatch between the code's nominal scope (a single beta-blocker medication) and the actual work being solicited suggests limited or misaligned activity under this specific commodity designation. State and local governments using this code tag are currently focused on community health support systems and pharmacy program modernization rather than propranolol procurement specifically.

Seminole County, Florida issued an IFB in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county's community health building; the bid deadline was July 26, 2023. The Texas Health and Human Services Commission released an RFI in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs for self-insured employee health plans and state agencies, with no formal award amount or timeline specified at that exploratory stage. The issuing bodies span state health agencies and county health departments. Geographic activity is concentrated in Florida and Texas based on recent postings, though the small sample and thematic divergence from the code's nominal scope suggest either sparse relevant activity under this commodity designation or systematic miscoding of health-supply and pharmacy-program opportunities.